Health
Roche gantenerumab improves biomarkers in inherited form of Alzheimer’s disease – PMLiVE
However, anti-amyloid antibody did not show evidence of cognitive benefit for patients
A new study, published in Nature Medicine, has showed that Roche’s investigational candidate gantenerumab led to improvements in a number of biomarkers in patients with an inherited form of Alzheimer’s disease.
In the DIAN-TU-001 trial, researchers from…
Continue Reading
-
Noosa News15 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General19 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General8 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Business24 hours agoTop brokers name 3 ASX shares to buy next week 5 October 2025